Podcasts

Articles

Webinars

Peer-Reviewed

Videos

American College of Cardiology

Patients who cardiologists see once every few months are getting handed over to pharmacists who can monitor them more frequently and get them to their goals, said Crystal Zhou, PharmD, assistant professor of Clinical Pharmacy at the University of California, San Francisco (UCSF).

Dr Crystal Zhou Discusses Incorporating Pharmacists Into the Cardiology Care Team

Patients often have comorbidities that make it important to consider them holistically and not bucket them into one disease state, and the findings on rivaroxaban show broad benefits and a favorable risk-benefit profile, said Marc Bonaca, MD, MPH, of CPC Clinical Research and CPC Community Health and the University of Colorado School of Medicine.

Consider the Whole Patient When Choosing Treatment, Says Dr Marc Bonaca

Treating children with familial hypercholesterolemia (FH) early can help reduce progression of atherosclerosis without adverse events related to growth and development, said Raul Santos, MD, PhD, director, Lipid Clinic at the Heart Institute, and associate professor, University of São Paulo Medical School, Brazil.

Dr Raul Santos Explains the Benefits of Treating Children With FH Early

Even as virtual care has dropped from the peaks at the beginning of the pandemic, some aspects of it will not go away in cardiology care, said Dipti Itchhaporia, MD, FACC, the 70th president of the American College of Cardiology.

Dr Dipti Itchhaporia Highlights Aspects of Virtual Care Here to Stay

Patients hospitalized for acute heart failure and prescribed empagliflozin saw improvements in quality of life at 15 and 90 days post-discharge. The study may make the case for prescribing SGLT2 inhibitors before patients leave the hospital. 

EMPULSE: Empagliflozin Yields QOL Benefits in Patients Hospitalized for Acute HF 

Researchers presented new data on patient characteristics and outcomes seen in the VICTORIA trial of vericiguat. 

Updated Analyses From VICTORIA Trial Presented at ACC 2022

Experts outlined updates in the use of artificial intelligence, wearable devices, and artificial wombs for cardiac health during a session at the American College of Cardiology (ACC)’s 71st Scientific Sessions. 

AI, Wearable Devices, and Artificial Wombs: ACC Session Highlights Advancements in Cardiac Technology

There is some confusion about the differences between the European and American guidelines on lowering low-density lipoprotein (LDL) cholesterol, but it’s clear that lower is better, said Pam Taub, MD, FACC, professor of medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine. 

Dr Pam Taub Emphasizes Lower Is Better for LDL Cholesterol Levels

The new guidelines also call for better incorporation and addressing of social determinants of health. 

New HF Definition, Stage Updates Outlined in 2022 ACC/AHA/HFSA Guidelines

Additional analyses from the SCORED trial further highlight sotagliflozin's benefits among patients with type 2 diabetes and chronic kidney disease, regardless of cardiovascular disease presence.